نتائج البحث - Vikram Pattanayak

  • يعرض 1 - 13 نتائج من 13
تنقيح النتائج
  1. 1
    Tebentafusp in the Treatment of Metastatic Uveal Melanoma: Patient Selection and Special Considerations

    Tebentafusp in the Treatment of Metastatic Uveal Melanoma: Patient Selection and Special Considerations حسب Kamaneh Montazeri, Vikram Pattanayak, Ryan J. Sullivan

    منشور في 2023
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Determining the Specificities of TALENs, Cas9, and Other Genome-Editing Enzymes

    Determining the Specificities of TALENs, Cas9, and Other Genome-Editing Enzymes حسب Vikram Pattanayak, John P. Guilinger, David R. Liu

    منشور في 2014
    احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Revealing off-target cleavage specificities of zinc-finger nucleases by in vitro selection

    Revealing off-target cleavage specificities of zinc-finger nucleases by in vitro selection حسب Vikram Pattanayak, Cherie L. Ramirez, J. Keith Joung, David R. Liu

    منشور في 2011
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Small molecule–triggered Cas9 protein with improved genome-editing specificity

    Small molecule–triggered Cas9 protein with improved genome-editing specificity حسب Kevin M Davis, Vikram Pattanayak, David B. Thompson, John A. Zuris, David R. Liu

    منشور في 2015
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity

    High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity حسب Vikram Pattanayak, Steven Lin, John P. Guilinger, Enbo Ma, Jennifer A. Doudna, David R. Liu

    منشور في 2013
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    731. High-Fidelity CRISPR-Cas9 Nucleases with No Detectable Genome-Wide Off-Target Effects

    731. High-Fidelity CRISPR-Cas9 Nucleases with No Detectable Genome-Wide Off-Target Effects حسب Benjamin P. Kleinstiver, Vikram Pattanayak, Michelle S. Prew, Shengdar Q. Tsai, Nathalie T. Nguyen, J. Keith Joung

    منشور في 2016
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    High-fidelity CRISPR–Cas9 nucleases with no detectable genome-wide off-target effects

    High-fidelity CRISPR–Cas9 nucleases with no detectable genome-wide off-target effects حسب Benjamin P. Kleinstiver, Vikram Pattanayak, Michelle S. Prew, Shengdar Q. Tsai, Nathalie T. Nguyen, Zongli Zheng, J. Keith Joung

    منشور في 2016
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    Broad specificity profiling of TALENs results in engineered nucleases with improved DNA-cleavage specificity

    Broad specificity profiling of TALENs results in engineered nucleases with improved DNA-cleavage specificity حسب John P. Guilinger, Vikram Pattanayak, Deepak Reyon, Shengdar Q. Tsai, Jeffry D. Sander, J. Keith Joung, David R. Liu

    منشور في 2014
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    Analysis of off-target effects in CRISPR-based gene drives in the human malaria mosquito

    Analysis of off-target effects in CRISPR-based gene drives in the human malaria mosquito حسب William T. Garrood, Nace Kranjc, Karl Petri, Daniel Y. Kim, Jimmy A. Guo, Andrew Hammond, Ioanna Morianou, Vikram Pattanayak, J. Keith Joung, Andrea Crisanti, Alekos Simoni

    منشور في 2021
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    In silico abstraction of zinc finger nuclease cleavage profiles reveals an expanded landscape of off-target sites

    In silico abstraction of zinc finger nuclease cleavage profiles reveals an expanded landscape of off-target sites حسب Jeffry D. Sander, Cherie L. Ramirez, Samantha J Linder, Vikram Pattanayak, Noam Shoresh, Manching Ku, Jennifer A Foden, Deepak Reyon, B Bernstein, David R. Liu, J. Keith Joung

    منشور في 2013
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  11. 11
    Suboptimal antibody response against SARS-CoV-2 Omicron variant after third dose of mRNA vaccine in kidney transplant recipients

    Suboptimal antibody response against SARS-CoV-2 Omicron variant after third dose of mRNA vaccine in kidney transplant recipients حسب Ayman Al Jurdi, Rodrigo Benedetti Gassen, Thiago J. Borges, Isadora T. Lape, Leela Morená, Orhan Efe, Zhabiz Solhjou, Rania El Fekih, Christa Deban, Brigid Bohan, Vikram Pattanayak, Camille N. Kotton, Jamil Azzi, Leonardo V. Riella

    منشور في 2022
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  12. 12
    CRISPR-Cas9 treatment partially restores amyloid-β 42/40 in human fibroblasts with the Alzheimer’s disease PSEN1 M146L mutation

    CRISPR-Cas9 treatment partially restores amyloid-β 42/40 in human fibroblasts with the Alzheimer’s disease PSEN1 M146L mutation حسب Evangelos Konstantinidis, Agnieszka Molisak, Florian Perrin, Linn Streubel-Gallasch, Sarah M. Fayad, Daniel Y. Kim, Karl Petri, Martin J. Aryee, Ximena Aguilar, Bence György, Vilmantas Giedraitis, J. Keith Joung, Vikram Pattanayak, Magnus Essand, Anna Erlandsson, Oksana Berezovska, Martin Ingelsson

    منشور في 2022
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  13. 13
    A Code of Ethics for Gene Drive Research

    A Code of Ethics for Gene Drive Research حسب George J. Annas, Chase L. Beisel, Kendell Clement, Andrea Crisanti, Stacy A. Francis, Marco Galardini, Roberto Galizi, Julian Grünewald, Greta Immobile, Ahmad S. Khalil, Ruth Müller, Vikram Pattanayak, Karl Petri, Ligi Paul, Luca Pinello, Alekos Simoni, Chrysanthi Taxiarchi, J. Keith Joung

    منشور في 2021
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: